Zhang Song, Yi Hongli, Jiang Shujuan, Li Yuantang, Wang Yongkang
Department of Respiratory Medicine, Provincial Hospital Affiliated to Shandong University, Jinan 250021, China.
Zhongguo Fei Ai Za Zhi. 2010 May;13(5):447-50. doi: 10.3779/j.issn.1009-3419.2010.05.13.
Transbronchial needle aspiration (TBNA) and endobronchial ultrasound-guided TBNA (EBUS-TBNA) have been applied to the diagnosis for mediastinal lymph nodes. The aim of this study is to evaluate the clinical value and safety of TBNA and EBUS-TBNA on hilar and mediastinal lymph nodes of lung cancer patients.
Two hundred fifty patients with suspected lung cancer were enrolled. All petients with hilar and/or m lymphoadenopa-ediastinal thy found by CT scan received TBNA, biopsy and brushing. EBUS-TBNA was performed in 15 patients among them.
Lung cancer were confirmed in 180 patients by TBNA, biopsy and brushing. The positive rates were 82.86%, 51.24% and 45.45%. Fifteen patients after EBUS-TBNA had a positive rate of 91.67%.
TBNA and EBUS-TBNA were proved to be safe procedure with a high yield for the diagnosis ofhilar and mediastinal lymph nodes in lung cancer patients.
经支气管针吸活检术（TBNA）和超声支气管镜引导下经支气管针吸活检术（EBUS-TBNA）已应用于纵隔淋巴结的诊断。本研究旨在评估TBNA和EBUS-TBNA对肺癌患者肺门和纵隔淋巴结的临床诊断价值及安全性。
纳入250例疑似肺癌患者。所有经CT扫描发现有肺门和/或纵隔淋巴结肿大的患者均接受TBNA、活检及刷检。其中15例患者接受了EBUS-TBNA。
通过TBNA、活检及刷检确诊肺癌180例。阳性率分别为82.86%、51.24%和45.45%。15例行EBUS-TBNA的患者阳性率为91.67%。
TBNA和EBUS-TBNA被证明是诊断肺癌患者肺门和纵隔淋巴结安全且阳性率高的方法。
